ClinicalTrials.gg
CompletedNCT06130878Updated Oct 27, 2026

Rhythmic Exercise in Older Adults With Cognitive Impairment

An interventional study of Rhythmic exercise in Cognitive Impairment, sponsored by University of Jaén. Completed at 1 site in Spain. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-10-27.

Sponsored by University of Jaén · Not applicable, Interventional, and Treatment

How we know

Updated Oct 27, 2026Start date movedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
96
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 162 studies in Cognitive Dysfunction with a site in Spain — 44 open to participants now, 61 under way, 9 of them phase 3. Cognitive Dysfunction · Spain.

Enrollment
73rd of 127
96 · median 100
Started
2024
with 16 others
No phase
91 of 162
27 open now
Registered
109th of 162
by date
Lead sponsor
4 of 162
University of Jaén

Among the 162 studies in Cognitive Dysfunction with a site in Spain, this one is the 73rd largest by enrollment of the 127 interventional ones that give a count, is one of 17 that started in 2024, is one of 91 with no phase, and was the 109th registered.

Cognitive Dysfunction

3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.

Browse Cognitive Dysfunction studies →

Open to participants now

44 of the 162 studies in Cognitive Dysfunction with a site in Spain are open now. Recruiting first, the newest first:

39 more — sign in →

All 44 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.

This study: 60 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 162 studies in Cognitive Dysfunction with a site in Spain, or all of them as a file.
02

Study summary

Rhythmic physical exercise is a very promising non-pharmaceutical tool to prevent or reduce cognitive decline that occurs in people sixty years of age or older. The main objective is to determine the effect of a rhythmic exercise program on the physical, mental and cognitive performance of older adults with cognitive impairment. The main variables of the study will be: global cognitive function evaluated by the Mini Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA); attention and executive functions evaluated using the Trail Making Test (TMT) part A and B. As secondary variables, the functional abilities evaluated using the Senior Fitness Test (SFT) will be taken into account. Additionally, sociodemographic variables and variables related to health status will be evaluated. These will take into account the quality of sleep evaluated with the Pittsburgh index, the nutritional status evaluated using the Mini Nutritional Assessment-Short Form (MNA-SF) scale, and the Stress and anxiety levels will be assessed using the Depression Anxiety Stress Scales-21 (DASS-21). All variables will be evaluated before the intervention and after it. After the intervention, it is expected that the exercise program will improve the neurocognitive performance, as well as the functional and psychological abilities of older adults.

03

Conditions studied

  • Cognitive Impairment
04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Be 60 years old or older
  • Do not participate in any physical exercise program
  • Present physical autonomy to participate in the physical activities required by the study.
  • Present scores of > 25 on the
  • Present current affiliation to the social health security system.
  • Sign the
  • Understand the instructions, programs and protocols of this project.
  • Complete more than 90% of the intervention with exercise.

Exclusion criteria

Exclusion Criteria:

  • Present medical for performing physical tests.
  • Present diseases that limit cognitive performance and physical activity.
  • Present vestibular diseases
  • Present rheumatological diseases that can be exacerbated by stress articulate.
  • Refusing to sign the
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
96 participants (actual)

Study arms

  • No intervention
    Control Group (CG)

    This group does not receive any treatment.

  • Experimental
    EXPERIMENTAL GROUP (EG)

    People assigned to this group will undergo a 12-week physical training intervention

    Other: Rhythmic exercise

Interventions

  • OtherRhythmic exercise

    A multicomponent rhythmic physical training will be carried out, with a predominance of QMT, following the principles of "Animal Flow" \[46\] and including the following components: wrist mobilizations; activations; specific stretching positions; special locomotor movements or "traveling forms"; interruptions and transitions with dynamic movements and choreographic sequences of "Flow". Aspects related to the control of intensity, volume and progression strategy have yet to be defined.

06

What researchers measure

Primary outcomes

  1. MoCA (Montreal Cognitive Assessment)

    Instrument that examines the skills of attention, concentration, executive functions, memory, language, visuoconstructive abilities, calculation and orientation and the maximum score is 30.

    Time frame: Up to twelve weeks

  2. TMT (Trail Making Test)

    It is used to assess executive function. It measures timed motor and visual tasks, and is divided into two tests: Part A (TMTA), which assesses speed and psychomotor attention and requires connecting consecutively numbered circles; and Part B (TMTB), which tests executive function and requires connecting alternating circles of numbers and letters. Longer completion times indicate poor performance.

    Time frame: Up to twelve weeks

  3. Mini-Mental State Examination (MMSE)

    The most widely used cognitive screening test to assess suspected symptoms consistent with cognitive impairment or dementia. Written test with a maximum score of 30. The cut-off point established for the MMSE defines "normal" cognitive function is generally set at 24, lower scores indicate more serious cognitive problems.

    Time frame: Up to twelve weeks

  4. SFT (Senior Fitness Test)

    Instrument used to assess functional abilities. It consists of the following tests: muscle strength (upper and lower limbs), aerobic endurance, flexibility (upper and lower limbs) and agility, 6-minute walk test, Sit-to-foot test using a chair (measures flexibility of the lower body, Try to clasp hands behind your back, Try to get up, walk 8 feet and sit back.

    Time frame: Up to twelve weeks

  5. The Short Form-36 Health Survey (SF-36)

    Used extensively for assessing health-related quality of life. The results are values between 0 and 100. Optimal health is represented by scores of 100 and very poor health would equal 0.

    Time frame: Up to twelve weeks

  6. Chair sit and reach test

    To test low back and hamstring flexibility.

    Time frame: Up to twelve weeks

  7. Back scratch test

    To measure general shoulder range of motion.

    Time frame: Up to twelve weeks

  8. PSQI (Pittsburgh Sleep Quality Index)

    A simple and valid assessment of both sleep quality and disturbance that might affect. They consist of 10 questions divided into four subscales: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep discomfort, medication use and daytime dysfunctions, adding up to a total score. The higher value represents a worse result. Higher scores indicate poorer sleep.

    Time frame: Up to twelve weeks

  9. The Yesavage Geriatric Depression Scale

    Questionnaire used to screen for depression in older people. Scores from 00 to 05 indicate Normal screening, 06 to 10 Moderate Depression screening, and 11 to 15 Severe Depression screening.

    Time frame: Up to twelve weeks

Secondary outcomes

  1. Tinetti scale

    It is used to determine early the risk of falling in an elderly person during the year following its application. The result of both sections will be added, so that a score of less than 19 points will imply a high risk of falls, a score of 19 to 24 will reflect medium risk of falls and a score of 25 to 28 will indicate low risk of falls.

    Time frame: Up to twelve weeks

  2. Frailty phenotype

    Five original characteristics are evaluated: involuntary weight loss, self-reported exhaustion, slow gait speed, weakness, and low physical activity.

    Time frame: Up to twelve weeks

  3. Handgrip Strength

    Dynamometer will be employed to assess hand grip strength.

    Time frame: Up to twelve weeks

  4. Mindful Attention Awareness Scale (MAAS)

    It evaluates, in a global way, the dispositional capacity of an individual to be attentive and aware of the experience of the present moment in everyday life. The scale is a 15-item univariate self-report with a view of the mindfulness construct centered on the attention / consciousness variable.

    Time frame: Up to twelve weeks

07

Study locations

1 site
  • U.E.D. Virgen de la Capilla
    Jaén, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2024 to primary completion in Apr 2024, 2 months.

Of 1,453 non-industry interventional studies with no phase under Cognitive Dysfunction, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 51. This study's 2 months is below that.

Counting every sponsor, half of 1,522 studies reached it within 27 months; a quarter within 12 and three quarters within 50.

Primary completion moved once since we started tracking on Sep 25, 2026: Jan 2024 → Apr 2024, on Oct 27, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Nov 8, 2023
First posted
Nov 14, 2023
StartActual
Jan 29, 2024
Primary completionActual
Apr 25, 2024was Jan 2024
CompletionActual
Apr 30, 2024
Last update
Oct 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Jan 8, 2024→Jan 29, 2024
Oct 27, 2026
Primary completion
Jan 15, 2024→Apr 25, 2024
Oct 27, 2026
Study completion
Apr 5, 2024→Apr 30, 2024
Oct 27, 2026
Show all 1 update
  1. Oct 27, 2026
    Start date Jan 8, 2024→Jan 29, 2024
    Primary completion Jan 15, 2024→Apr 25, 2024
    Study completion Apr 5, 2024→Apr 30, 2024
    + 2 other changes: index terms and verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06130878
Lead sponsor
University of Jaén
Responsible party
Agustín Aibar Almazán (Principal investigator, University of Jaén) — Principal investigator
First posted
Nov 14, 2023
Start date
Jan 29, 2024
Primary completion
Apr 25, 2024
Completion
Apr 30, 2024
Last update
Oct 27, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion